CARLSBAD, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of United States Patent No: 11,331,199 entitled "Spinal Implant for Motion Preservation or Fusion." This patent covers Aurora's ZIPFlex™ Technology for a minimally invasive posterior interlaminar implant for motion preservation that could be adapted into a fusion or non-fusion device while implanted in a patient via a small modular attachment.

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

This new patent covers interlaminar motion-preserving and fusion implants in one device that could treat lumbar spinal degenerative diseases, such as spinal stenosis. Over the last 50 years, spinal fusion has become the gold standard for treating several degenerative spinal disorders. Motion preservation surgeries are also popular since they avoid total fusion. A ZIPFlex Technology-based implant could be implanted as a motion preservation device and months or years later could be easily converted from motion preservation device to a fusion implant via a minor keyhole procedure by adding a blocker element at the center of the main body. Patented features of ZIPFlex™ include individually adjustable anchors to prevent implant migration and unnecessary bone removal to fit the implant. Aurora's ZIPFlex is the first technology to offer an all-in-one approach to providing viable options for treating patients with back pain.

"Some of the difficulty with traditional spinal fusion systems is that stabilization or additional fusion may be required intraoperatively, particularly to protect adjacent levels after spinal surgery and to protect degenerative segments following decompressive surgery," said Steven Falowski, M.D., Director of Functional Neurosurgery at Argires-Marotti Neurosurgical Associates of Lancaster, PA. "Aurora received the ZIPFlex patent, with its proprietary Modular In-Situ Fusion Block, a device that provides the surgeon with the ability to determine whether to stabilize or fuse a patient intraoperatively during the procedure or to allow motion preservation. This is a major step forward in delivering the best options long term for your patients.”

Mr. Trent Northcutt, President and Chief Executive Officer of Aurora Spine, stated, "As our IP portfolio continues to grow, so does the positive impact we can make for our physician customers and their patients. With this latest patent grant from the USPTO, we have further strengthened our value proposition and the depth and breadth of our portfolio of minimally invasive interlaminar devices.”

Mr. Laszlo Garamszegi, Chief Technology Officer of Aurora Spine, added, "We are excited to receive this patent covering the technology of our proposed ZIPFlex device. Aurora’s motto, “Simplifying the Complex” is the focus of every product we create. The “two-in-one” ZIPFlex device patent is another example of how the company is working to build upon its IP and offer our customers highly technical products that contain an 'ease of use' element.”

Aurora Spine focuses on bringing new solutions to the spinal implant market through innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company's products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any information that expresses or involves discussions as to expectations, beliefs, plans, objectives, assumptions, or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions, and uncertainties that could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release, and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

Trent Northcutt President and Chief Executive Officer (760) 424-2004

Chad Clouse Chief Financial Officer (760) 424-2004 www.aurora-spine.com

Adam Lowensteiner LYTHAM PARTNERS, LLC Phoenix | New York Telephone: 646-829-9700 asapf@lythampartners.com

The stock of the oil giant have been sliding of late but should receive a boost as the Oracle of Omaha buys more of its shares.

Gold futures edged up on Friday, but posted a loss of 0.6% for the week, as copper prices suffered their largest weekly drop since June of last year. "Gold remains trapped in a range as traders await to see if the latest inflation reports will force the [Federal Reserve] into committing to more massive rate hikes beyond the July policy meeting," said Edward Moya, senior market analyst at OANDA. Meanwhile, worries about an economic recession continued to feed expectations for a drop in copper dem

Mia Cosmetic Factory had already been serving as exclusive partner of Gotha Cosmetics for three years.

“As CEO, my focus is maximizing total shareholder return, driven by improved revenue quality, higher margins, and a balanced capital allocation strategy,” said new CEO Raj Subramaniam on the call.

Editor’s note: This story is part of the 2022 edition of Middle Market 75, a joint project between the San Francisco Business Times and Silicon Valley Business Journal to track growth at companies with between $25 million and $1 billion in annual revenue over a two-year period, from 2019 to 2021. Company: Affirm Location: San Francisco Rank on Middle Market 75 List: 1 Founder: Max Levchin, a member of the so-called "Paypal mafia" that founded the groundbreaking payments company. Founded: 2012 CEO: Max Levchin What they do: Affirm Holdings is a pioneer in Buy Now Pay Later, a technology that allows customers at Affirm's participating retailers to split even relatively small purchases into a series of monthly or twice-monthly payments.

Media reports from earlier this week said it was in discussions with Alphabet Inc's Google and Comcast Corp's NBCUniversal for potential marketing tie-ups. "We're talking to all of them right now," Sarandos said at the Cannes Lions conference when asked which company Netflix was looking to partner with. Alphabet and Comcast did not immediately respond to Reuters requests for comment.

In the wake of the Supreme Court’s decision Friday overturning Roe v. Wade, which eliminates the constitutional right to abortion, Google has notified American employees that it will allow them to relocate to another state — no questions asked. In a memo Friday (via CNBC), Fiona Cicconi, Google’s chief people officer, reiterated that the internet […]

CarMax reported better-than-expected quarterly earnings early Friday as strong pricing for used cars offset weaker volumes. CarMax stock jumped Friday, retaking a key level. "GPUs (gross profit per unit) were especially strong, above the historical band despite the increase in wholesale prices," Stephens analyst Daniel Imbro wrote in a note to clients on Friday.

(Bloomberg) -- A dispute over one of the biggest copper and cobalt mines is escalating in the Democratic Republic of Congo, threatening to disrupt exports of essential battery materials and raising questions about the project’s future.Most Read from BloombergElon Musk Says New Tesla Plants Are ‘Money Furnaces’ Losing BillionsThe World’s Bubbliest Housing Markets Are Flashing Warning SignsJuul Soon to Be Ordered Off the Market by FDA, WSJ ReportsRecession Worries Boost Treasuries; Stocks Advance:

Short-Bitcoin ETF BITI had a slow first week. Did that mark the crypto bottom after ProShares launched its Bitcoin ETF BITO near the top?

"There's a delay in home ownership." Housing prices and inflation have made it hard to buy a home, but ownership is still key to building wealth.

(Bloomberg) -- Crypto brokerage firm Voyager Digital Ltd. is limiting customer withdrawals from its platform to $10,000 and to 20 transactions during a 24-hour period. Most Read from BloombergJuul’s Vaping Products Are Ordered Off the Market in the USElon Musk Says New Tesla Plants Are ‘Money Furnaces’ Losing BillionsThese Are the World’s Most Liveable Cities in 2022Recession Worries Boost Treasuries; Stocks Advance: Markets WrapThe World’s Bubbliest Housing Markets Are Flashing Warning SignsThe

U.S. stocks closed higher in a choppy session Thursday following Federal Reserve Chair Jerome Powell's second day of testimony on Capitol Hill.

The latest price moves in bitcoin ($BTC) and crypto markets in context, for June 24, 2022.

Brazil's central bank is aiming for inflation in 2023 "around" the 3.25% target but less than 4%, its chief, Roberto Campos Neto, said on Thursday, as policymakers hike interest rates to cool surging consumer prices in Latin America's largest economy. When it raised its key interest rate to 13.25% last week and penciled in another hike for August, the central bank said it was looking to ensure inflation next year converged "around the target" rather than "to its target." "Around is less than 4%, just to make that very clear," Campos Neto said in an online news conference.

Gold futures ended lower on Thursday, with prices for the precious metal down a fourth straight session. Losses for gold are "mainly due to the strength in the dollar, as expectations are that [the Federal Reserve] may adopt even more hawkish monetary policy," Naeem Aslam, chief market analyst at AvaTrade, told MarketWatch. In testimony before the House Financial Services Committee Thursday, Fed Chairman Jerome Powell said he has an "unconditional" commitment" to fight inflation. August gold fel

Last year, used-car retailers were on a roll, fueled by new-vehicle shortages, low interest rates and a strong consumer. CarMax the largest such retailer in the U.S., reported on Friday that its total revenue grew 21% in the quarter ended May 31 compared with a year earlier—higher than the 18% increase analysts polled by Visible Alpha were expecting. The boost in revenue was mostly thanks to higher prices: While CarMax sold 11% fewer used cars, consumers had to shell out $6,311 more per vehicle on average, a 28% increase from a year earlier.

(Bloomberg) -- Wall Street’s biggest banks are set to return tens of billions of dollars to investors after all the lenders passed the Federal Reserve’s annual test of their ability to withstand market turmoil.Most Read from BloombergSupreme Court Overturns Roe, Transforming Abortion-Rights FightJuul’s Vaping Products Are Ordered Off the Market in the USThese Are the World’s Most Liveable Cities in 2022Elon Musk Says New Tesla Plants Are ‘Money Furnaces’ Losing BillionsStocks Surge as Bullard, D

Enanta Pharmaceuticals (ENTA) filed a lawsuit against Pfizer (PFE) over Paxlovid, alleging that the COVID-19 antiviral expected to bring in $22 billion in sales this year is based on a patent first filed by Enanta scientists. The suit, which was filed Tuesday in U.S. District Court in Massachusetts, alleges that Enanta filed an application with the U.S. Patent and Trademark Office “describing coronavirus protease inhibitors invented by Enanta scientists” in July 2020. Pfizer’s patent for Paxlovid appears to have been filed three months later, and Enanta’s patent “does appear to cover the chemical space Paxlovid is in,” RBC Capital Markets analyst Brian Abrahams told investors this week.

(Bloomberg) -- JPMorgan Asset Management is doubling down on China tech stocks after enduring a tumultuous selloff, betting that an easing of regulatory crackdowns and attractive valuations will pay off well. Most Read from BloombergElon Musk Says New Tesla Plants Are ‘Money Furnaces’ Losing BillionsThe World’s Bubbliest Housing Markets Are Flashing Warning SignsJuul Soon to Be Ordered Off the Market by FDA, WSJ ReportsRecession Worries Boost Treasuries; Stocks Advance: Markets WrapThese Are the